E-cigarette use and respiratory disorders: An integrative review of converging evidence from epidemiological and laboratory studies

European Respiratory Journal

Volumn 57, Issue 1, 2021, Pages

  Wills, Thomas A ^a   Soneji, Samir S ^b   Choi, Kelvin ^c   Jaspers, Ilona ^d   Tam, Elizabeth K ^e  

^a UNIVERSITY OF HAWAII CANCER CENTER   (United States)

^b DARTMOUTH INSTITUTE FOR HEALTH POLICY AND CLINICAL PRACTICE   (United States)

^c NATIONAL INSTITUTE ON MINORITY HEALTH AND HEALTH DISPARITIES   (United States)

^d UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF HAWAII   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCEROL; PROPYLENE GLYCOL;

ARTICLE; ASTHMA; BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; CYTOTOXICITY; EAST ASIAN; FLORIDA; GENE EXPRESSION; HIGH SCHOOL STUDENT; HUMAN; IMMUNITY; INFECTION SENSITIVITY; INFLAMMATION; OXIDATIVE STRESS; RESPIRATORY TRACT DISEASE; SECONDARY ORGANIC AEROSOL; SWEDEN; SYSTEMATIC REVIEW; UNITED STATES; VAPING; ADOLESCENT; ADVERSE EVENT; CROSS-SECTIONAL STUDY; ELECTRONIC CIGARETTE; LABORATORY; META ANALYSIS; TOBACCO; YOUNG ADULT;

ADOLESCENT; CROSS-SECTIONAL STUDIES; ELECTRONIC NICOTINE DELIVERY SYSTEMS; HUMANS; LABORATORIES; TOBACCO PRODUCTS; VAPING; YOUNG ADULT;

EID: 85100280546     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/13993003.01815-2019     Document Type: Article

References (132)

1. Wang TW, Gentzke A, Sharapova S, et al. Tobacco product use among middle and highschool students - United States, 2011-2017. MMWR Morb Mortal Wkly Rep 2018; 67: 629-633.
2. Schulenberg JE, Johnston LD, O'Malley PM, et al. Monitoring the Future: National Survey Results on Drug Use, 1975-2018. Vol. II. College Students and Adults Ages 19-60. Ann Arbor: Institute for Social Research, University of Michigan, 2019.
3. Miech RA, Johnston LD, O'Malley PM, et al. Adolescent vaping and nicotine use in 2017-2018: U.S. national estimates. N Engl J Med 2019; 380: 192-193.
4. Cullen KA, Gentzke AS, Sawdey MD, et al. E-cigarette use among youth in the United States, 2019. JAMA 2019; 322: 2095-2103.
5. Murthy VH. E-cigarette use among youth and young adults: a major public health concern. JAMA Pediatr 2017; 171: 209-210.
6. Thorndike AN. E-cigarette use by young adult nonsmokers: next-generation nicotine dependence? Ann Intern Med 2019; 170: 70-71.
7. Besaratinia A, Tommasi S. Vaping: a growing global health concern. EClinicalMedicine 2019; 17: 100208.
8. Perez M, Crotty Alexander LE. Why is vaping going up in flames? Ann Am Thorac Soc 2020; 17: 545-549.
9. Glantz SA, Bareham DW. E-cigarettes: use, effects on health, risks, and policy implications. Ann Rev Public Health 2018; 39: 215-235.
10. Soneji S, Barrington-Trimis JL, Wills TA, et al. Association between initial use of e-cigarettes and subsequent cigarette smoking among adolescents and young adults: a systematic review and meta-analysis. JAMA Pediatr 2017; 171: 788-797.
11. National Academies of Sciences, Engineering, and Medicine. Public Health Consequences of E-cigarettes. Washington, DC, National Academies Press, 2018.
12. Landman S, Dhaliwal I, Mackenzie CA, et al. Life-threatening bronchiolitis related to electronic cigarette use in a Canadian youth. CMAJ 2019; 191: E1321-E1331.
13. Hua M, Talbot P. Potential health effects of electronic cigarettes: a systematic review of case reports. Prev Med Rep 2016; 4: 169-178.
14. Arter ZL, Wiggins A, Hudspath C, et al. Acute eosinophilic pneumonia following e-cigarette use. Resp Med Case Rep 2019; 27: 100825.
15. Bradford LE, Rebuli ME, Ring BJ, et al. Danger in the vapor? ECMO for adolescents with status asthmaticus after vaping. J Asthma 2020; 57: 1168-1172.
16. Itoh M, Aoshiba K, Herai Y, et al. Lung injury associated with electronic cigarettes inhalation diagnosed by transbronchial lung biopsy. Respir Case Rep 2017; 6: e00282.
17. Sommerfeld CG, Weiner DJ, Nowalk A, et al. Hypersensitivity pneumonitis and acute respiratory distress syndrome from e-cigarette use. Pediatrics 2018; 141: e20163927.
18. Lange P, Celli B, Agustí A, et al. Lung-function trajectories leading to chronic obstructive pulmonary disease. N Engl J Med 2015; 373: 111-122.
19. Santillan AA, Camargo CA, Colditz GA. A meta-analysis of asthma and risk of lung cancer (United States). Cancer Causes Control 2003; 14: 327-334.
20. Tagiyeva N, Devereux G, Fielding S, et al. Outcomes of childhood asthma and wheezy bronchitis: 50-year cohort study. Am J Respir Crit Care Med 2016; 193: 23-30.
21. Bhatnagar A. E-cigarettes and cardiovascular disease risk: evaluation of evidence, policy implications, and recommendations. Curr Cardiovasc Risk Rep 2016; 10: 24.
22. Bold KW, Krishnan-Sarin S, Stoney CM. E-cigarette use as a potential cardiovascular disease risk behavior. Am Psychol 2018; 73: 955-967.
23. Chen H, Li G, Chan YL, et al. Maternal e-cigarette exposure in mice alters DNA methylation and lung cytokine expression in offspring. Am J Respir Cell Mol Biol 2018; 58: 366-377.
24. McGrath-Morrow SA, Hayashi M, Aherrera A, et al. The effects of electronic cigarette emissions on systemic cotinine levels, weight and postnatal lung growth in neonatal mice. PLoS One 2015; 10: e0118344.
25. Nguyen T, Li GE, Chen H, et al. Maternal e-cigarette exposure results in cognitive and epigenetic alterations in offspring in a mouse model. Chem Res Toxicol 2018; 31: 601-611.
26. Zakarya R, Adcock I, Oliver BG. Epigenetic impacts of maternal tobacco and e-vapour exposure on the offspring lung. Clin Epigenetics 2019; 11: 32.
27. Chun LF, Moazed F, Calfee CS, et al. Pulmonary toxicity of e-cigarettes. Am J Physiol Lung Cell Mol Physiol 2017; 313: L193-L206.
28. Clapp PW, Jaspers I. Electronic cigarettes: their constituents and potential links to asthma. Curr Allergy Asthma Rep 2017; 17: 79.
29. Wills TA, Knight R, Williams R, et al. Risk factors for exclusive e-cigarette use and dual e-cigarette and tobacco use in adolescents. Pediatrics 2015; 135: e43-e51.
30. Wills TA, Gibbons FX, Sargent JD, et al. How is the effect of e-cigarette use on smoking onset mediated: a longitudinal analysis. Psychol Addict Behav 2016; 30: 876-886.
31. Wills TA, Knight R, Sargent JD, et al. Longitudinal study of e-cigarette use and onset of cigarette smoking among high school students in Hawaii. Tob Control 2017; 26: 34-39.
32. Cho JH, Paik SM. Association between electronic cigarette use and asthma among high school students in South Korea. PLoS One 2016; 11: e0151022.
33. Kim SY, Sim S, Choi HG. Active, passive, and electronic cigarette smoking is associated with asthma in adolescents. Sci Rep 2017; 7: 17789.
34. Lee A, Lee SY, Lee K-S. The use of heated tobacco products is associated with asthma, allergic rhinitis, and atopic dermatitis in Korean adolescents. Sci Rep 2019; 9: 17699.
35. Wang MP, Ho SY, Leung LT, et al. Electronic cigarette use and respiratory symptoms in Chinese adolescents in Hong Kong. JAMA Pediatr 2016; 170: 89-91.
36. Choi K, Bernat D. E-cigarette use among Florida youth with and without asthma. Am J Prev Med 2016; 51: 446-453.
37. Fedele DA, Barnett TE, Dekevich D, et al. Prevalence of and beliefs about electronic cigarettes and hookah among high school students with asthma. Ann Epidemiol 2016; 26: 865-869.
38. Bayly JE, Bernat D, Porter L, et al. Secondhand exposure to aerosols from electronic nicotine delivery systems and asthma exacerbations among youth with asthma. Chest 2019; 155: 88-93.
39. Larsen K, Faulkner GEJ, Boak A, et al. Looking beyond cigarettes: are Ontario adolescents with asthma less likely to smoke e-cigarettes, marijuana, waterpipes or tobacco cigarettes? Respir Med 2016; 120: 10-15.
40. Schweitzer RJ, Wills TA, Tam E, et al. E-cigarette use and asthma in a multiethnic sample of adolescents. Prev Med 2017; 105: 226-231.
41. Wills TA, Choi K, Pagano I. E-cigarette use associated with asthma independent of cigarette smoking and marijuana in a 2017 national sample of adolescents. J Adolesc Health 2020; 67: 524-530.
42. McConnell R, Barrington-Trimis JL, Wang K, et al. Electronic cigarette use and respiratory symptoms in adolescents. Am J Respir Crit Care Med 2017; 195: 1043-1049.
43. Wang JB, Olgin JE, Nah G, et al. Cigarette and e-cigarette dual use and risk of cardiopulmonary symptoms in the Health eHeart Study. PLoS One 2018; 13: e0198681.
44. Wills TA, Pagano I, Williams RJ, et al. E-cigarette use and respiratory disorder in an adult sample. Drug Alcohol Depend 2019; 194: 363-370.
45. Osei AD, Mirbolouk M, Orimoloye OA, et al. The association between e-cigarette use and asthma among never combustible cigarette smokers: Behavioral Risk Factor Surveillance System (BRFSS) 2016 & 2017. BMC Pulm Med 2019; 19: 180.
46. Bhatta DN, Glantz SA. Association of e-cigarette use with respiratory disease among adults: a longitudinal analysis. Am J Prev Med 2020; 58: 182-190.
47. Strong DR, Myers MG, Pulvers K, et al. Marijuana use among US tobacco users: findings from wave 1 of the Population Assessment of Tobacco Health (PATH) study. Drug Alcohol Depend 2018; 186: 16-22.
48. Perez M, Atuegwu NC, Mead EL, et al. Adult e-cigarette use associated with a self-reported diagnosis of COPD. Int J Environ Res Public Health 2019; 16: 3938.
49. Li D, Sundar IK, McIntosh S, et al. Association of smoking and electronic cigarette use with wheezing and related respiratory symptoms in adults: cross-sectional results from the Population Assessment of Tobacco and Health (PATH) study, wave 2. Tob Control 2020; 29: 140-147.
50. Osei AD, Mirbolouk M, Orimoloye OA, et al. Association between e-cigarette use and chronic obstructive pulmonary disease by smoking status: Behavioral Risk Factor Surveillance System 2016 and 2017. Am J Prev Med 2020; 58: 336-342.
51. Hedman L, Backman H, Stridsman C, et al. Association of electronic cigarette use with smoking habits, demographic factors, and respiratory symptoms. JAMA Netw Open 2018; 1: e180789.
52. Bowler RP, Hansel NH, Jacobson S, et al. Electronic cigarette use in US adults at risk for or with COPD: analysis from two observational cohorts. J Gen Intern Med 2017; 32: 1315-1322.
53. Brener ND, Billy JOG, Grady WR. Assessment of factors affecting the validity of self-reported health risk behavior among adolescents: a review of the literature. J Adolesc Health 2003; 33: 437-457.
54. Del Boca FK, Darkes J. The validity of self-reports of alcohol consumption: state of the science and challenges for research. Addiction 2003; 98: Suppl. 2, 1-12.
55. Brener ND, Kann L, McManus T, et al. Reliability of the 1999 Youth Risk Behavior Survey questionnaire. J Adolesc Health; 2002: 336-342.
56. Brener ND, Kann L, Shanklin S, et al. Methodology of the Youth Risk Behavior Surveillance System - 2013. MMWR Recomm Rep 2013; 62: 1-20.
57. Hu SS, Pierannunzi C, Balluz L. Integrating a multimode design into a national random-digit-dialed telephone survey. Prev Chronic Dis 2011; 8: A145.
58. Li C, Balluz LS, Ford ES, et al. A comparison of prevalence estimates for selected health indicators of chronic diseases or conditions from the Behavioral Risk Factor Survey Surveillance System, the National Health Interview Survey, and the National Health and Nutrition Examination Survey, 2007-2008. Prev Med 2012; 54: 381-387.
59. Pierannunzi C, Hu SS, Balluz L. A systematic review of publications assessing reliability and validity of the Behavioral Risk Factor Surveillance System (BRFSS), 2004-2011. BMC Med Res Methodol 2013; 13: 49.
60. Williams M, Villarreal A, Bozhilov K, et al. Metal and silicate particles including nanoparticles are present in electronic cigarette cartomizer fluid and aerosol. PLoS One 2013; 8: e57987.
61. Zhao J, Zhang Y, Sisler JD, et al. Assessment of reactive oxygen species generated by electronic cigarettes using acellular and cellular approaches. J Hazard Mater 2018; 344: 549-557.
62. Bals R, Boyd J, Esposito S, et al. Electronic cigarettes: a task force report from the European Respiratory Society. Eur Respir J 2019; 53: 1801151.
63. Ahmad S, Zafar I, Mariappan N, et al. Acute pulmonary effects of aerosolized nicotine. Am J Physiol Lung Cell Mol Physiol 2019; 316: L94-L104.
64. Behar RZ, Wang Y, Talbot P. Comparing the cytotoxicity of electronic cigarette fluids, aerosols and solvents. Tob Control 2018; 27: 325-333.
65. Goniewicz ML, Smith DM, Edwards KC, et al. Comparison of nicotine and toxicant exposure in users of electronic cigarettes and combustible cigarettes. JAMA Netw Open 2018; 1: e185937.
66. Erythropel HC, Jabba SV, DeWinter TM, et al. Formation of flavorant-propylene glycol adducts with novel toxicological properties in chemically unstable e-cigarette liquids. Nicotine Tob Res 2019; 21: 1248-1258.
67. Putzhammer R, Doppler C, Jakshcitz T, et al. Vapors of US and EU market leader electronic cigarette brands and liquids are cytotoxic for human vascular endothelial cells. PLoS One 2016; 11: e0157337.
68. Leigh NJ, Lawton RI, Hershberger PA, et al. Flavorings affect inhalation toxicity of aerosol generated from electronic nicotine delivery systems (ENDS). Tob Control 2016; 25: Suppl. 2, ii81-ii87.
69. Anderson C, Majeste A, Hanus J, et al. E-cigarette aerosol exposure induces reactive oxygen species, DNA damage, and cell death in vascular endothelial cells. Toxicol Sci 2016; 154: 332-340.
70. Rowell TR, Reeber SL, Lee SL, et al. Flavored e-cigarette liquids reduce proliferation and viability in the CALU3 airway epithelial cell line. Am J Physiol Lung Cell Mol Physiol 2017; 313: L52-L66.
71. Omaiye EE, McWhirter KJ, Luo W, et al. High-nicotine electronic cigarette products: toxicity of JUUL fluids and aerosols correlates strongly with nicotine and some flavor chemical concentrations. Chem Res Toxicol 2019; 32: 1058-1069.
72. Hua M, Omaiye EE, Luo W, et al. Identification of cytotoxic flavor chemicals in top-selling electronic cigarette refill fluids. Sci Rep 2019; 9: 2782.
73. Escobar Y-NH, Nipp G, Cui T, et al. In vitro toxicity and chemical characterization of aerosol derived from electronic cigarette humectants using a newly developed exposure system. Chem Res Toxicol 2020; 33: 1677-1688.
74. Hecker L. Mechanisms and consequences of oxidative stress in lung disease: therapeutic implications for an ageing populace. Am J Physiol Lung Cell Mol Physiol 2018; 314: L642-L653.
75. Scheffler S, Dieken H, Krischenowski O, et al. Evaluation of e-cigarette liquid vapor and mainstream cigarette smoke after direct exposure of primary human bronchial epithelial cells. Int J Environ Res Public Health 2015; 12: 3915-3925.
76. Schweitzer KS, Chen SX, Law S, et al. Endothelial disruptive proinflammatory effects of nicotine and e-cigarette vapor exposures. Am J Physiol Lung Cell Mol Physiol 2015; 309: L175-L187.
77. Crotty Alexander LEC, Drummond CA, Hepokoski M, et al. Chronic inhalation of e-cigarette vapor containing nicotine disrupts airway barrier function and induces systemic inflammation and multiorgan fibrosis in mice. Am J Physiol Regul Integr Comp Physiol 2018; 314: R834-R847.
78. Lerner CA, Sundar IK, Yao H, et al. Vapors produced by electronic cigarettes and e-juices with flavorings induce toxicity, oxidative stress, and inflammatory response in lung epithelial cells and in mouse lung. PLoS One 2015; 10: e0116732.
79. Ji EH, Sun B, Zhao T, et al. Characterization of electronic cigarette aerosol and its induction of oxidative stress response in oral keratinocytes. PLoS One 2016; 11: e0154447.
80. Larcombe AN, Janka MA, Mullins BJ, et al. The effects of electronic cigarette aerosol exposure on inflammation and lung function in mice. Am J Physiol Lung Cell Mol Physiol 2017; 313: L67-L79.
81. Chatterjee Shampa, Tao Jian-Qin, Johncola Alyssa, et al. Acute exposure to e-cigarettes causes inflammation and pulmonary endothelial oxidative stress in nonsmoking, healthy young subjects. Am J Physiol Lung Cell Mol Physiol 2019; 317: L155-L166.
82. Muthumalage T, Prinz M, Ansah KO, et al. Inflammatory and oxidative responses induced by exposure to commonly used e-cigarette flavoring chemicals and flavored e-liquids without nicotine. Front Physiol 2018; 8: 1130.
83. Scott A, Lugg ST, Aldridge K, et al. Pro-inflammatory effects of e-cigarette vapor condensate on human alveolar macrophages. Thorax 2018; 73: 1161-1169.
84. Wu Q, Jiang D, Minor M, et al. Electronic cigarette liquid increases inflammation and virus infection in primary human airway epithelial cells. PLoS One 2014; 9: e108342.
85. Hwang JH, Lyes M, Sladewski K, et al. Electronic cigarette inhalation alters innate immunity and airway cytokines while increasing the virulence of colonizing bacteria. J Mol Med 2016; 94: 667-679.
86. Sussan TE, Gajghate S, Thimmulappa RK, et al. Exposure to electronic cigarettes impairs pulmonary anti-bacterial and anti-viral defenses in a mouse model. PLoS One 2015; 10: e0116861.
87. Gilpin DF, McGown K-A, Gallagher K, et al. Electronic cigarette vapour increases virulence and inflammatory potential of respiratory pathogens. Respir Res 2019; 20: 267.
88. Gómez A-C, Rodríguez-Fernández P, Villar-Hernández R, et al. E-cigarettes: effects in phagocytosis and cytokines response against Mycobacterium tuberculosis. PLoS One 2020; 15: e0228919..
89. Madison M, Landers C, Gu B-H, et al. Electronic cigarettes disrupt lung lipid homeostasis and innate immunity independent of nicotine. J Clin Invest 2019; 129: 4290-4304.
90. Reidel B, Radicioni G, Clapp P, et al. E-cigarette use causes a unique innate immune response in the lung involving increased neutrophilic activation and altered mucin secretion. Am J Respir Crit Care Med 2018; 197: 492-501.
91. Garcia-Arcos I, Geraghty P, Baumlin N, et al. Chronic electronic cigarette exposure in mice induces features of COPD in a nicotine-dependent manner. Thorax 2016; 71: 1119-1129.
92. Ghosh A, Coakley RC, Masscenik T, et al. Chronic e-cigarette exposure alters the human bronchial epithelial proteome. Am J Respir Crit Care Med 2018; 198: 67-76.
93. Clapp PW, Lavrich KS, van Heusden CA, et al. Cinnamaldehyde in flavored e-cigarette liquids temporarily suppresses bronchial epithelial cell ciliary motility by dysregulation of mitochondrial function. Am J Physiol Lung Cell Mol Physiol 2019; 316: L470-L486.
94. Hickman E, Herrera CA, Jaspers I. Common e-cigarette flavoring chemicals impair neutrophil phagocytosis and oxidative burst. Chem Res Toxicol 2019; 32: 982-985.
95. Corriden R, Moshensky A, Bojanowski C, et al. E-cigarette use increases susceptibility to bacterial infection by impairment of human neutrophil chemotaxis, phagocytosis, and NET formation. Am J Physiol Cell Physiol 2020; 318: C205-C214.
96. Ghosh A, Coakley RD, Ghio AJ, et al. Chronic e-cigarette use increases neutrophil elastase and matrix metalloprotease levels in the lung. Am J Respir Crit Care Med 2019; 200: 1392-1401.
97. Higham A, Rattray NJW, Dewhurst JA, et al. Electronic cigarette exposure triggers neutrophil inflammatory responses. Respir Res 2016; 17: 56.
98. Clapp P, Pawlak E, Lackey J, et al. Flavored e-cigarette liquids and cinnamaldehyde impair respiratory innate immune cell function. Am J Physiol Lung Cell Mol Physiol 2017; 313: L278-L292.
99. Yu V, Rahimy M, Korrapati A, et al. Electronic cigarettes induce DNA strand breaks and cell death independently of nicotine in cell lines. Oral Oncol 2016; 52: 58-65.
100. Martin EM, Clapp PW, Rebuli ME, et al. E-cigarette use results in suppression of immune and inflammatory-response genes in nasal epithelial cells similar to cigarette smoke. Am J Physiol Lung Cell Mol Physiol 2016; 311: L135-L144.
101. Moses E, Wang T, Corbett S, et al. Molecular impact of electronic cigarette aerosol exposure in human bronchial epithelium. Toxicol Sci 2017; 155: 248-257.
102. Ganapathy V, Manyanga J, Brame L, et al. Electronic cigarette aerosols suppress antioxidant defenses and induce significant oxidative DNA damage. PLoS One 2017; 12: e0177780.
103. Muthumalage T, Lamb T, Friedman M, et al. E-cigarette flavored pods induce inflammation, epithelial barrier dysfunction, and DNA damage in lung epithelial cells and monocytes. Sci Rep 2019; 9: 19035.
104. Lee H-W, Park S-H, Weng M-W, et al. E-cigarette smoke damages DNA and reduces repair activity in mouse lung, heart, and bladder as well as in human lung and bladder cells. Proc Natl Acad Sci USA 2018; 115: E1560-E1569.
105. Tommasi S, Caliri AW, Caceres A, et al. Deregulation of biologically significant genes and associated molecular pathways in the oral epithelium of electronic cigarette users. Int J Mol Sci 2019; 20: 738.
106. Song M-A, Freudenheim JL, Brasky TM, et al. Biomarkers of exposure and effect in the lungs of smokers, nonsmokers, and electronic cigarette users. Cancer Epidemiol Biomarkers Prev 2020; 29: 443-451.
107. Shields PG, Song M-A, Freudenheim JL, et al. Electronic cigarettes and the lung proteome. Am J Respir Crit Care Med 2018; 198: 1350-1351.
108. Tarran R, Ghosh A, Alexis N. Reply to Shields et al.: electronic cigarettes and the lung proteome. Am J Respir Crit Care Med 2018; 198: 1351-1352.
109. Jasper AE, Sapey E, Thickett D, et al. Comment on “E-cigarette use increases susceptibility to bacterial infection by impairment of human neutrophil chemotaxis, phagocytosis, and NET formation”. Am J Physiol Cell Physiol 2020; 318: C704-C705.
110. Crotty Alexander LE, Meier A. Reply to Letter to the Editor: “Comment on 'E-cigarette use increases susceptibility to bacterial infection by impairment of human neutrophil chemotaxis, phagocytosis, and NET formation'”. Am J Physiol Cell Physiol 2020; 318: C706.
111. Kosmider L, Sobczak A, Prokopowicz A, et al. Cherry-flavored electronic cigarettes expose users to the inhalation irritant, benzaldehyde. Thorax 2016; 71: 376-377.
112. Hill AB. The environment and disease: association or causation? Proc R Soc Med 1965; 58: 295-300.
113. Hernán MA. The C-word: scientific euphemisms do not improve causal inference from observational data. Am J Public Health 2018; 108: 616-619.
114. Adami H-O, Berry CL, Breckenridge CB, et al. Toxicology and epidemiology: improving the science with a framework for combining toxicological and epidemiological evidence to establish causal inference. Toxicol Sci 2011; 122: 233-234.
115. Fedak KM, Bernal A, Capshaw ZA, et al. Applying the Bradford Hill criteria in the 21st century: how data integration has changed causal inference in molecular epidemiology. Emerg Themes Epidemiol 2015; 12: 14.
116. Chen H, Cohen P, Chen S. How big is a big odds ratio? Interpreting the magnitudes of odds ratios in epidemiological studies. Comm Stat Simul Comput 2010; 39: 860-864.
117. Blagev DP, Harris D, Dunn AC, et al. Clinical presentation, treatment, and short-term outcomes of lung injury associated with e-cigarettes or vaping: a prospective observational cohort study. Lancet 2019; 394: 2073-2083.
118. Layden JE, Ghinai I, Pray I, et al. Pulmonary illness related to e-cigarette use in Illinois and Wisconsin - final report. N Engl J Med 2020; 382: 903-916.
119. Ghinai I, Pray IW, Navon L, et al. E-cigarette product use, or vaping, among persons with associated lung injury - Illinois and Wisconsin, April-September 2019. MMWR Morb Mortal Wkly Rep 2019; 68: 865-869.
120. Kalininskiy A, Bach CT, Nacca NE, et al. E-cigarette, or vaping, product use associated lung injury (EVALI): case series and diagnostic approach. Lancet Respir Med 2019; 7: 1017-1026.
121. Triantafyllou GA, Tiberio PJ, Zou RH, et al. Vaping-associated lung injury: a case series. Am J Respir Crit Care Med 2019; 200: 1430-1431.
122. Krishnasamy VP, Hallowell BD, Ko JY, et al. Update: characteristics of a national outbreak of e-cigarette, or vaping, product use-associated lung injury, United States, August 2019-January 2020. MMWR Morb Mortal Wkly Rep 2020; 69: 90-94.
123. Blount BC, Karwowski MP, Shields PG, et al. Vitamin E acetate in bronchoalveolar-lavage fluid associated with EVALI. N Engl J Med 2020; 382: 697-705.
124. Bhat TA, Kalathil SG, Bogner PN, et al. An animal model of inhaled vitamin E acetate and EVALI-like lung injury. N Engl J Med 2020; 382: 1175-1177.
125. Ghinai I, Navon L, Gunn JKL, et al. Characteristics of persons who report using only nicotine-containing products among interviewed patients with e-cigarette, or vaping, product use-associated lung injury - Illinois, August-December 2019. MMWR Morb Mortal Wkly Rep 2020; 69: 84-89.
126. Crotty Alexander LE, Ware L, Calfee C, et al. E-cigarette or vaping product use-associated lung injury: developing a research agenda. An NIH workshop report. Am J Respir Crit Care Med 2020; 202: 795-802.
127. Chand HS, Muthumalage T, Maziak W, et al. Pulmonary toxicity and the pathophysiology of electronic cigarette, or vaping product, use associated lung injury. Front Pharmacol 2020; 10: 1619.
128. Crotty Alexander LE, Bellinghausen AL, Eakin MN. What are the mechanisms underlying vaping-induced lung injury? J Clin Invest 2020; 130: 2754-2756.
129. Eissenberg T, Maziak W. Are electronic cigarette users at risk for lipid-mediated lung injury? Am J Respir Crit Care Med 2020; 201: 1012-1013.
130. Chaumont M, van de Borne P, Bernard A, et al. Fourth-generation e-cigarette vaping induces transient lung inflammation and gas exchange disturbances: results from two randomized clinical trials. Am J Physiol Lung Cell Mol Physiol 2019; 316: L705-L719.
131. Erythropel HC, Davis LM, de Winter TM, et al. Flavor-solvent reaction products and menthol in JUUL e-cigarettes and aerosol. Am J Prev Med 2019; 57: 425-427.
132. Soneji SS, Sung H-Y, Primack BA, et al. Quantifying population-level benefits and harms of e-cigarette use in the United States. PLoS One 2018; 13: e0193328.